why novartis� landmark cancer drug approval is great news for bluebird http://lm360.us/Exford-grandpa-of-Turrie-from-Erhchiehtsun-(1)?Festamoth=144
in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance. .
executive director of saen michael budkie made these reports public in a letter addressed to chancellor carol christ on wednesday .